Inhibition of capsaicin-induced increase in dermal blood flow by the oral CGRP receptor antagonist, telcagepant (MK-0974)-Reference-Cited by-同舟云学术

Inhibition of capsaicin-induced increase in dermal blood flow by the oral CGRP receptor antagonist, telcagepant (MK-0974)

Published:2010-01 Issue:1 Volume:69 Page:15-22
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:

Author:

Sinclair Simon R.,Kane Stefanie A.,Van der Schueren Bart J.,Xiao Alan,Willson Kenneth J.,Boyle Janet,de Lepeleire Inge,Xu Yang,Hickey Lisa,Denney William S.,Li Chi-Chung,Palcza John,Vanmolkot Floris H. M.,DeprÃ© Marleen,Van Hecken Anne,Murphy M. Gail,Ho Tony W.,de Hoon Jay N.

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2125.2009.03543.x/fullpdf

Reference36 articles.

1. Molecular events in developmental regulation of neuroendocrine genes: characterization of the novel neuropeptide CGRP;Evans;Cold Spring Harb Symp Quant Biol,1983

2. Calcitonin gene-related peptide is a potent vasodilator;Brain;Nature,1985

3. Perivascular peptides relax cerebral arteries concomitant with stimulation of cyclic adenosine monophosphate accumulation or release of an endothelium-derived relaxing factor in the cat;Edvinsson;Neurosci Lett,1985

4. Calcitonin gene-related peptide (CGRP): perivascular distribution and vasodilatory effects;Uddman;Regul Pept,1986

5. Calcitonin gene-related peptide: exploring its vasodilating mechanism of action in humans;de Hoon;Clin Pharmacol Ther,2003

Cited by 80 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Elevated plasma levels of calcitonin gene‐related peptide in individuals with rosacea: A cross‐sectional case–control study;Journal of the European Academy of Dermatology and Venereology;2024-04

2. TRP channels and migraine;TRP Channels as Therapeutic Targets;2024

3. Non‐neuronal TRPA1 encodes mechanical allodynia associated with neurogenic inflammation and partial nerve injury in rats;British Journal of Pharmacology;2023-01-07

4. Pharmacokinetic and pharmacodynamic assessments of atogepant in healthy male adults: Results from phase 1 studies;Cephalalgia Reports;2023-01-01

5. Antiseizure medications for the prophylaxis of migraine during the anti-CGRP drugs era;Current Neuropharmacology;2022-12-28